BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 14, 2026
Home » Blogs » BioWorld MedTech Perspectives » Mind over matter

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Mind over matter

Feb. 27, 2013
By Omar Ford
brainweights

She was probably a little more than 5-feet-tall... and close to 160 pounds of pure muscle. On a day unlike any other, I crossed the path of this 60-year-old woman (though she doesn't look a day over 40) who is an avid bodybuilder, at the gym I often work out in.

We were both headed to a piece of equipment to do pull-ups - I was by myself, she was with a cadre of women that she was training. As I was about to get on the machine she cut me off rather quickly and hopped on it before I got the chance.

"Hey," I told her. "I was just going to get on that."

She gave a quick glance back toward me and rolled her eyes. She then proceeded to do about 50 pulls ups before stepping away from the machine.

No doubt physical fitness is a main priority for her as it is for a great deal of enthusiasts at the gym, but are they focused on their mental fitness or their brain health? Shortly after I had my encounter with her, I had the chance to talk to a company called SharpBrains, a firm that serves as an advocate for brain health.

It was amazing to me that in my discussion with SharpBrains CEO Alvaro Fer­nan­dez, that there is a cultural shift regarding neurological diseases and that many companies are developing programs and techniques to prevent these diseases from setting in.

The market for this concept is rapidly growing – expected to jump from the current level of $1 billion to about $6 billion in 2020 – according to the SharpBrains newly released study, the Digital Brain Health Market 2012-2020.

The 211-page market report tracks developments at more than fifty public and private companies offering fully automated applications designed to assess, monitor and/or enhance cognition and brain functioning, and provides industry data, insights and analysis to help executives, entrepreneurs, technology/health innovators and policy makers navigate the opportunities and risks of the rapidly growing Digital Brain Health field.

In summary, he said that patients are going to be doing more and more to preserve their brain health alongside their physical health. So the next time I see my 60-year-old workout nemesis, it might be worth a mention to her to look into what the company is doing - that is if I can muster up the courage to look her in the eye after our last encounter.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 13, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 13, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Icons representing scientific research

    Science in 2025: the best of the rest

    BioWorld Science
    A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing